MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population

Overview

Journal Mol Diagn Ther

Specialties Molecular Biology
Pathology
Pharmacology

Date 2016 Jul 15

PMID 27412345

Citations 3

Authors

Sarra Bchir

Hela Ben Nasr

Amel Ben Anes

Mohamed Benzarti

Abdelhamid Garrouch

Zouhair Tabka

Karim Chahed

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to determine the role of MMP-1 (-1607 1G/2G; -519 A/G) and MMP-2 (-1306 C/T; -735 C/T) polymorphisms in the development and severity of chronic obstructive pulmonary disease (COPD) in Tunisian patients. We also evaluated the impact of these genetic variants on serum levels of the corresponding proteins.

Methods: The study included 138 patients with COPD and 216 healthy controls. Pulmonary function was evaluated using body plethysmography, and COPD severity was determined based on forced expiratory volume in 1 s (FEV1%). MMP-1 and MMP-2 variants were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), while serum matrix metalloproteinase (MMP)-1 and -2 levels were determined by enzyme-linked immunosorbent assay (ELISA) and activity of MMP-2 was determined by gelatin zymography.

Results: No significant associations were found between genetic variations in MMP-1 and MMP-2 variants and the risk of development of COPD. Additionally, no significant impact of the MMP-1 (-1607 1G/2G; -519 A/G) and MMP-2 (-735 C/T) polymorphisms was observed on the respective protein levels and clinical parameters of the disease. Interestingly, a significant correlation was identified between the MMP-2 (-1306) C/T and disease severity [p = 0.01; Bonferroni corrected p value (p ) = 0.04]. Increased levels of MMP-2 were also identified in patients with the MMP-2 (-1306) CC genotype compared with those with CT and TT genotypes (105 [84.69-121.5] vs. 86.29 [80.99-92.62] ng/ml; p = 0.01, p = 0.04). Additionally, MMP-2 activity was enhanced in patients carrying the CC genotype compared with those carrying the T variant (p = 0.01, p = 0.02).

Conclusion: Our data suggest that, although MMP-1 (-1607 1G/2G; -519 A/G) and MMP-2 (-735 C/T) may not affect COPD risk and clinical parameters, the MMP-2 (-1306C/T) variant was correlated to COPD severity. These findings could be related to alterations in the level and activity of MMP-2 in serum from patients carrying the (-1306) CC genotype.

Citing Articles

Association between MMP2 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population.

Li S, Zeng X, Wang S, Xie X, Lan J ESC Heart Fail. 2023; 10(3):1793-1802.

PMID: 36866790 PMC: 10192288. DOI: 10.1002/ehf2.14333.

Impact of rs243865 and rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients.

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B Mediators Inflamm. 2021; 2021:5573642.

PMID: 33986628 PMC: 8079184. DOI: 10.1155/2021/5573642.

Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.

Chen L, Chiu K, Hsia T, Lee Y, Shen T, Li C In Vivo. 2020; 34(6):3181-3186.

PMID: 33144422 PMC: 7811679. DOI: 10.21873/invivo.12153.

References

Korytina G, Tselousova O, Akhmadishina L, Victorova E, Zagidullin S, Victorova T . [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease]. Mol Biol (Mosk). 2012; 46(3):487-99. View

Jurajda M, Muzik J, Izakovicova Holla L, Vacha J . A newly identified single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene. Mol Cell Probes. 2002; 16(1):63-6. DOI: 10.1006/mcpr.2001.0398. View

Zhang D, Wang J, Zhang G, Chu X, Zhang J, Zhou Y . Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer. Int J Clin Exp Med. 2016; 8(11):20391-401. PMC: 4723800. View

Price S, Greaves D, Watkins H . Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2000; 276(10):7549-58. DOI: 10.1074/jbc.M010242200. View

Benbow U, Tower G, Wyatt C, Buttice G, Brinckerhoff C . High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem. 2002; 86(2):307-19. DOI: 10.1002/jcb.10225. View

Birbian N, Singh J, Jindal S . Highly Protective Association of MMP-2-1306C/T Promoter Polymorphism With Asthma in a North Indian Population: A Pilot Study. Allergy Asthma Immunol Res. 2014; 6(3):234-41. PMC: 4021242. DOI: 10.4168/aair.2014.6.3.234. View

Ingram J, Slade D, Church T, Francisco D, Heck K, Sigmon R . Role of Matrix Metalloproteinases-1 and -2 in Interleukin-13-Suppressed Elastin in Airway Fibroblasts in Asthma. Am J Respir Cell Mol Biol. 2015; 54(1):41-50. PMC: 4742923. DOI: 10.1165/rcmb.2014-0290OC. View

Yoshida T, Kato K, Fujimaki T, Yokoi K, Oguri M, Watanabe S . Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nephrol. 2009; 4(5):883-90. PMC: 2676181. DOI: 10.2215/CJN.04350808. View

Bidan C, Veldsink A, Meurs H, Gosens R . Airway and Extracellular Matrix Mechanics in COPD. Front Physiol. 2015; 6:346. PMC: 4667091. DOI: 10.3389/fphys.2015.00346. View

10.

Takeyabu K, Betsuyaku T, Nishimura M, Yoshioka A, Tanino M, Miyamoto K . Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J. 1998; 12(5):1033-9. DOI: 10.1183/09031936.98.12051033. View

11.

Srivastava P, Gangwar R, Kapoor R, Mittal R . Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers. 2010; 29(1):37-46. PMC: 3835524. DOI: 10.3233/DMA-2010-0724. View

12.

Slattery M, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L . Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One. 2013; 8(5):e63165. PMC: 3655963. DOI: 10.1371/journal.pone.0063165. View

13.

Baraldo S, Bazzan E, Zanin M, Turato G, Garbisa S, Maestrelli P . Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest. 2007; 132(6):1733-40. DOI: 10.1378/chest.06-2819. View

14.

Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D . Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004; 64(20):7622-8. DOI: 10.1158/0008-5472.CAN-04-1521. View

15.

Visse R, Nagase H . Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92(8):827-39. DOI: 10.1161/01.RES.0000070112.80711.3D. View

16.

Joos L, He J, Shepherdson M, Connett J, Anthonisen N, Pare P . The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002; 11(5):569-76. DOI: 10.1093/hmg/11.5.569. View

17.

Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen Y . Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest. 1998; 78(9):1077-87. View

18.

Rutter J, Mitchell T, Buttice G, Meyers J, Gusella J, Ozelius L . A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998; 58(23):5321-5. View

19.

Wang H, Ogawa M, Wood J, Bartolomei M, Sammel M, Kusanovic J . Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet. 2008; 17(8):1087-96. DOI: 10.1093/hmg/ddm381. View

20.

Mauviel A . Cytokine regulation of metalloproteinase gene expression. J Cell Biochem. 1993; 53(4):288-95. DOI: 10.1002/jcb.240530404. View